Digital Breast Tomosynthesis Market Size Estimated to Reach $3.18 Billion by 2025

Digital Breast Tomosynthesis Market Overview
Digital Breast Tomosynthesis Market size is estimated to reach $3.18 Bn by 2025, growing at a CAGR of 11.1% during the forecast period 2020-2025. Breast tomosynthesis which is also known as 3-D mammography and Digital Breast Tomosynthesis (DBT), a strengthened form of breast imaging that uses an x-ray of low dose to create a three-dimensional images of the breast. Every year about 2.1 million women are affected by breast cancer and in 2018 it is set to be that 627,000 women dead by breast cancer. The increase in the use of tomosynthesis over the traditional method is driving the market growth. The advancement of the latest technology and increasing prevalence of breast cancer globally are driving the growth of digital breast tomosynthesis during the forecast period 2020-2025.

Key Takeaways
Geographically, North America’s Digital Breast Tomosynthesis Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the availability of advanced medical health care technology.
The increase in health concern and increased prevalence of breast cancer are driving the market for Digital Breast Tomosynthesis during the forecast period 2020-2025.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Digital Breast Tomosynthesis Market report.
The advantages of the three-dimension mammography technology over the two-dimensional procedure is boosting the market growth for the Digital Breast Tomosynthesis.

Digital Breast Tomosynthesis Market Segment Analysis – By Product Type
The Product type segment of the Digital Breast Tomosynthesis Market has 2D/3D combination and Standalone 3D systems. The 2D/3D combination segment registers for the highest market share in 2019 and is set to be the fastest growing with a CAGR of 13.7% during the forecast period 2020-2025, owing to the increased breast cancer patients and increase in awareness about the three-dimensional procedures which are more effective than the two-dimensional process. Rising awareness among the patients about the 2D/3D combination system is driving the market in this segment. Standalone 3D systems have more advantages than the 2D system and development in new technology in this segment is driving the market 3D system segment during the forecast period 2020-2025.

Digital Breast Tomosynthesis Market Segment Analysis – By End Users
The End-users segment of the Digital Breast Tomosynthesis Market has Hospitals, Diagnostic centers and Others. The Hospitals segment registers for the highest market share in 2019 and is set to continue for the forecast period 2020-2025, owing to the increase in the prevalence of breast cancer across the globe. The increase in the technology in the hospitals and increased health care infrastructure is driving digital breast tomosynthesis in the hospital segment. The increase in the number of diagnostic centers globally is supporting the digital breast tomosynthesis market in the diagnostic segment during the forecast period 2020-2025. The increase in funding by the government and private sectors for the development is increasing the usage of digital breast tomosynthesis in research and development sectors during the forecast period 2020-2025.

Digital Breast Tomosynthesis Market Segment Analysis – By Geography
Based on Geography the global Digital Breast Tomosynthesis Market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. North America had a dominant share in terms of revenue in 2019 with a market share of 39.1% globally. This is owing to the increasing in spending on healthcare by the people. The increase in population and an increasing in the prevalence of breast cancer is driving the market for the digital breast tomosynthesis market in the Asia-pacific region during the forecast period 2020-2025. The increasing funding by the public and private companies and establishments of companies in developing countries are supporting the growth of the market in different regions during the forecast period 2020-2025

Digital Breast Tomosynthesis Market Drivers
High prevalence of breast cancer
The increase in the prevalence of breast cancer globally and the increase in health care among people are driving the market during the forecast period. Advancement of the three-dimensional mammography technology for the early detection of the cancer is boosting the market for the digital breast tomosynthesis market during the forecast period 2020-2025.

Digital Breast Tomosynthesis Market Challenges
The increase in the radiation during the procedure, an increase in scanning time may damage the cells and this is hampering the market growth. High operation cost and unavailability of the labor for these complex procedures are challenging the market during the forecast period 2020-2025.

Digital Breast Tomosynthesis Industry outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Digital Breast Tomosynthesis Market. Key companies of this market are Hologic Inc., Dexela Ltd., Planmed OY, Siemens Healthineers, Fujifilm Corporation, GE Healthcare, Metaltronica Spa, Internazionale Medico Scientifica S.r.l., Medi-Future, PerkinElmer, and others.

Acquisitions/Product Launches:
In March 2019, Fujifilm Medical systems lnc., has got FDA approval for the three new imaging processing systems, S-view, Iterative Super-resolution Reconstruction (ISR) and Tomosynthesis Spot-innovative tool for the high imaging quality at the low dose.
In April 2015, Siemens company got approval for the MAMMOMAT Revelation mammography system, It consists of the new features like InSpect imaging tool and HD Breast Biopsy solution, that is used for the early detection of cancer.